CIK 0001812364 · Large accelerated filer
Relay Therapeutics, Inc.
Sign in to watch- Ticker
- RLAY
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-370-8837
- Business address
- 60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
- 4 Planned sale President, R&D sold 93,456 shares at $16.94 ($1,583,145)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Financial Officer sold 17,717 shares at $12.86 ($227,841)
- 4 Open-market sale Chief Financial Officer sold 972 shares at $14.79 ($14,376)
- 4 Open-market sale See remarks sold 753 shares at $14.79 ($11,137)
- 4 Open-market sale President, R&D sold 1,490 shares at $14.79 ($22,037)
- 4 Planned sale Chief Financial Officer sold 19,517 shares at an average $13.19 ($257,498)
- 4 Planned sale Chief Financial Officer sold 17,717 shares at $10.06 ($178,233)
- 4 Open-market sale President, R&D sold 21,581 shares at an average $7.72 ($166,677)
- 4 Open-market sale See remarks sold 13,038 shares at an average $7.71 ($100,473)
- 4 Open-market sale Chief Financial Officer sold 15,515 shares at an average $7.71 ($119,631)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 16 · 320 filings